Literature DB >> 21460324

HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.

Somnuek Sungkanuparph1, Rebecca Oyomopito, Sunee Sirivichayakul, Thira Sirisanthana, Patrick C K Li, Pacharee Kantipong, Christopher K C Lee, Adeeba Kamarulzaman, Liesl Messerschmidt, Matthew G Law, Praphan Phanuphak.   

Abstract

Of 682 antiretroviral-naïve patients initiating antiretroviral therapy in a prospective, multicenter human immunodeficiency virus type 1 (HIV-1) drug resistance monitoring study involving 8 sites in Hong Kong, Malaysia, and Thailand, the prevalence of patients with ≥1 drug resistance mutation was 13.8%. Primary HIV drug resistance is emerging after rapid scaling-up of antiretroviral therapy use in Asia.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21460324      PMCID： PMC3070033          DOI： 10.1093/cid/cir107

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  36 in total

1.  Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.

Authors:  V Picard; E Angelini; A Maillard; E Race; F Clavel; G Chêne; F Ferchal; J M Molina
Journal:  J Infect Dis       Date:  2001-08-07       Impact factor: 5.226

Review 2.  Rates of transmission of antiretroviral drug resistant strains of HIV-1.

Authors:  Palanee Ammaranond; Philip Cunningham; Robert Oelrichs; Kazuo Suzuki; Claire Harris; Leakhena Leas; Andrew Grulich; David A Cooper; Anthony D Kelleher
Journal:  J Clin Virol       Date:  2003-02       Impact factor: 3.168

3.  Prevalence of genotypic resistance in untreated HIV patients in Spain.

Authors:  J M Eiros; C Labayru; B Hernández; M Ortega; P Bachiller; R Ortiz de Lejarazu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-04-19       Impact factor: 3.267

4.  Drug resistance mutations among HIV-1 strains from antiretroviral-naive patients in Martinique, French West Indies.

Authors:  R Césaire; G Dos Santos; S Abel; O Bera; G Sobesky; A Cabié
Journal:  J Acquir Immune Defic Syndr       Date:  1999-12-01       Impact factor: 3.731

5.  Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).

Authors:  B A Larder; S D Kemp
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

6.  Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.

Authors:  C Balotta; A Berlusconi; A Pan; M Violin; C Riva; M C Colombo; A Gori; L Papagno; S Corvasce; R Mazzucchelli; G Facchi; R Velleca; G Saporetti; M Galli; S Rusconi; M Moroni
Journal:  Antivir Ther       Date:  2000-03

7.  Antiretroviral-drug resistance among patients recently infected with HIV.

Authors:  Susan J Little; Sarah Holte; Jean-Pierre Routy; Eric S Daar; Marty Markowitz; Ann C Collier; Richard A Koup; John W Mellors; Elizabeth Connick; Brian Conway; Michael Kilby; Lei Wang; Jeannette M Whitcomb; Nicholas S Hellmann; Douglas D Richman
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

8.  Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors.

Authors:  Sunee Sirivichayakul; Kiat Ruxrungtham; Chaiwat Ungsedhapand; Wichai Techasathit; Sasiwimol Ubolyam; Theshinee Chuenyam; Sean Emery; David Cooper; Joep Lange; Praphan Phanuphak
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

9.  Time trends in primary HIV-1 drug resistance among recently infected persons.

Authors:  Robert M Grant; Frederick M Hecht; Maria Warmerdam; Lea Liu; Teri Liegler; Christos J Petropoulos; Nicholas S Hellmann; Margaret Chesney; Michael P Busch; James O Kahn
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

10.  Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.

Authors:  Chaiwat Ungsedhapand; Preeyaporn Srasuebkul; Peter Cardiello; Kiat Ruxrungtham; Winai Ratanasuwan; Eugene D M B Kroon; Metta Tongtalung; Nittaya Juengprasert; Sasiwimol Ubolyam; Umaporn Siangphoe; Sean Emery; Joep M A Lange; David A Cooper; Praphan Phanuphak
Journal:  J Acquir Immune Defic Syndr       Date:  2004-06-01       Impact factor: 3.731
View more
  23 in total

1.  Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia.

Authors:  Kok Keng Tee; Rami Kantor; Somnuek Sungkanuparph; Yutaka Takebe; Patrick Li; Rossana Ditangco; Praphan Phanuphak; Thira Sirisanthana; Benedict Sim; Winai Ratanasuwan; Pacharee Kantipong; Adeeba Kamarulzaman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

Review 2.  Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review.

Authors:  Kathryn M Stadeli; Douglas D Richman
Journal:  Antivir Ther       Date:  2012-10-10

3.  Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.

Authors:  Karidia Diallo; Du-Ping Zheng; Erin K Rottinghaus; Orji Bassey; Chunfu Yang
Journal:  AIDS Res Hum Retroviruses       Date:  2015-02-05       Impact factor: 2.205

4.  A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.

Authors: 
Journal:  AIDS Res Hum Retroviruses       Date:  2016-05-03       Impact factor: 2.205

5.  Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia.

Authors:  Praphan Phanuphak; Sunee Sirivichayakul; Awachana Jiamsakul; Somnuek Sungkanuparph; Nagalingeswaran Kumarasamy; Man Po Lee; Thira Sirisanthana; Pacharee Kantipong; Christopher Lee; Adeeba Kamarulzaman; Mahiran Mustafa; Rossana Ditangco; Tuti Merati; Winai Ratanasuwan; Thida Singtoroj; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

6.  Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals.

Authors:  Awachana Jiamsakul; Romanee Chaiwarith; Nicolas Durier; Sunee Sirivichayakul; Sasisopin Kiertiburanakul; Peter Van Den Eede; Rossana Ditangco; Adeeba Kamarulzaman; Patrick C K Li; Winai Ratanasuwan; Thira Sirisanthana
Journal:  J Med Virol       Date:  2015-07-17       Impact factor: 2.327

7.  Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.

Authors:  Theppharit Panichsillapakit; Davey M Smith; Joel O Wertheim; Douglas D Richman; Susan J Little; Sanjay R Mehta
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

8.  Rilpivirine resistance-associated mutations among antiretroviral-naive patients infected with HIV-1 in Asia.

Authors:  Somnuek Sungkanuparph; Awachana Jiamsakul; Sasisopin Kiertiburanakul; Sunee Sirivichayakul; Jutarat Praparattanapan; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

9.  Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.

Authors:  Rebecca A Oyomopito; Patrick C K Li; Somnuek Sungkanuparph; Praphan Phanuphak; Kok Keng Tee; Thira Sirisanthana; Pacharee Kantipong; Shinichi Oka; Chris K C Lee; Adeeba Kamarulzaman; Jun Yong Choi; Annette H Sohn; Matthew Law; Yi-Ming A Chen
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

Review 10.  The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis.

Authors:  Haochu Li; Gifty Marley; Wei Ma; Chongyi Wei; Mellanye Lackey; Qingyan Ma; Françoise Renaud; Marco Vitoria; Rachel Beanland; Meg Doherty; Joseph D Tucker
Journal:  AIDS Behav       Date:  2017-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.